C. Holladay

Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.

A. K. Levinson, P. Shrake, F. Schnell, 2003, The Journal of urology.

Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques.

A. K. Levinson, P. Shrake, F. Schnell, 1999, Urology.

Simultaneous irradiation for prostate cancer: intermediate results with modern techniques.

A. K. Levinson, F. Schnell, J. Benton, 2000, The Journal of urology.

The PSA nadir that indicates potential cure after radiotherapy for prostate cancer.

A. K. Levinson, W. H. Williams, F. Critz, 1997, Urology.

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.

A. K. Levinson, J. Benton, W. H. Williams, 2000, Journal of Urology.

Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer.

W. H. Williams, F. Critz, C. Holladay, 1997, Urology.

Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy.

A. K. Levinson, W. H. Williams, F. Critz, 1999, The Journal of urology.

Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation.

W. H. Williams, F. Critz, C. Holladay, 1998, The cancer journal from Scientific American.